Interactions between ibogaine, a potential anti-addictive agent, and morphine: an in vivo microdialysis study
Mechanisms Preclinical high
AI-extracted · unverified · confirm at source
First in vivo microdialysis of ibogaine–morphine DA interactions. Ibogaine decreased striatal DA, increased prefrontal DA, and blocked morphine-induced DA rise 19 h post-dose across three brain regions.
Dosing: 40 mg/kg (rat, i.p.) (intraperitoneal)